title: Immunolocalization and challenge studies using a recombinant Vibrio cholerae ghost expressing Trypanosoma brucei Ca(2+) ATPase (TBCA2) antigen.
abstract: Human African trypanosomiasis is a neglected disease caused by Trypanosoma brucei spp. A parasite cation pump (Ca(2+) ATPase; TBCA2) essential for survival and cation homeostasis was identified and characterized. It was hypothesized that targeting this pump using a Vibrio cholerae ghost (VCG)-based vaccine could protect against murine T. brucei infection. mRNA and protein expression of TBCA2 was differentially expressed in blood and insect stages of parasites and immunolocalized in the pericellular membrane and the flagellar pocket of bloodstream forms. Antigen-specific antibodies and Th1 cytokines, interleukin-2, interferon-gamma, and tumor necrosis factor-alpha were induced in rVCG-TBCA2-immunized mice and in vitro on antigen stimulation of splenic immune T cells, but the corresponding Th2-type response was unremarkable. Despite an increased median survival of 6 days in vaccinated mice, the mice were not protected against infection. Thus, immunization of mice produced robust parasite-specific antibodies but failed to protect mice against parasite challenge.
authors.affiliation: Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, Georgia 30310, USA. kramey@msm.edu
authors.forename: Kiantra
authors.initials: K
authors.lastname: Ramey
authors.forename: Francis O
authors.initials: FO
authors.lastname: Eko
authors.forename: Winston E
authors.initials: WE
authors.lastname: Thompson
authors.forename: Henry
authors.initials: H
authors.lastname: Armah
authors.forename: Joseph U
authors.initials: JU
authors.lastname: Igietseme
authors.forename: Jonathan K
authors.initials: JK
authors.lastname: Stiles
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan / Q000276:immunology / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000276:immunology / Q000378:metabolism*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D051379:Mice; D008807:Mice, Inbred BALB C; D016052:Protozoan Vaccines / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D014346:Trypanosoma brucei brucei / Q000201:enzymology*; D014353:Trypanosomiasis, African / Q000276:immunology*; D014734:Vibrio cholerae / Q000235:genetics* / Q000276:immunology / Q000378:metabolism
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016052:Protozoan Vaccines; D012333:RNA, Messenger; D000252:Calcium-Transporting ATPases
references.citation: Appl Biochem Biotechnol. 1992 Jun;33(3):183-92
references.pmid: 1444354
references.citation: Biol Chem. 1997 Sep;378(9):1039-46
references.pmid: 9348114
references.citation: PLoS Pathog. 2008 May 30;4(5):e1000078
references.pmid: 18516300
references.citation: Vaccine. 1994 Oct;12(13):1231-7
references.pmid: 7530888
references.citation: J Immunol Methods. 1999 Nov 19;230(1-2):59-70
references.pmid: 10594354
references.citation: Endocrinology. 2001 Sep;142(9):4076-85
references.pmid: 11517187
references.citation: Biochem J. 2000 Apr 1;347 Pt 1:243-53
references.pmid: 10727425
references.citation: J Eukaryot Microbiol. 1993 May-Jun;40(3):311-6
references.pmid: 8508168
references.citation: Mol Microbiol. 2005 Feb;55(4):1034-45
references.pmid: 15686552
references.citation: Biochim Biophys Acta. 1996 May 6;1286(1):1-51
references.pmid: 8634322
references.citation: Biochem J. 1993 Dec 15;296 ( Pt 3):759-63
references.pmid: 8280074
references.citation: Infect Immun. 1999 Jun;67(6):3128-32
references.pmid: 10338530
references.citation: Eur J Immunol. 1996 Jun;26(6):1359-64
references.pmid: 8647217
references.citation: J Protozool. 1987 Nov;34(4):465-73
references.pmid: 2828605
references.citation: Vaccine. 1994 Nov;12(14):1330-4
references.pmid: 7856300
references.citation: J Bacteriol. 1986 Aug;167(2):447-54
references.pmid: 3525513
references.citation: J Biol Chem. 1994 Oct 21;269(42):26045-51
references.pmid: 7929316
references.citation: J Biol Chem. 1993 Apr 25;268(12):8564-8
references.pmid: 8473301
references.citation: Vaccine. 1995 Feb;13(2):151-4
references.pmid: 7625108
references.citation: Ann Trop Med Parasitol. 2003 Jun;97(4):351-66
references.pmid: 12831521
references.citation: J Biol Chem. 1992 Mar 25;267(9):6020-6
references.pmid: 1556113
references.citation: Mol Cell Biol. 1998 Apr;18(4):2309-23
references.pmid: 9528801
references.citation: Vaccine. 2003 Apr 2;21(15):1694-703
references.pmid: 12639492
references.citation: Infect Immun. 1988 Jan;56(1):92-8
references.pmid: 3335412
references.citation: Ann Trop Med Parasitol. 2001 Dec;95(8):797-810
references.pmid: 11784434
references.citation: Anat Rec. 1999 Sep 1;256(1):40-8
references.pmid: 10456984
references.citation: Mol Biochem Parasitol. 2000 Feb 5;105(2):261-71
references.pmid: 10693748
references.citation: Exp Parasitol. 1996 Jun;83(1):134-46
references.pmid: 8654542
references.citation: Antimicrob Agents Chemother. 1998 Oct;42(10):2668-73
references.pmid: 9756774
references.citation: Mem Inst Oswaldo Cruz. 1992 Oct-Dec;87(4):517-23
references.pmid: 1343666
references.citation: Res Microbiol. 1990 Sep-Oct;141(7-8):1005-7
references.pmid: 2101465
references.citation: Infect Immun. 1998 Sep;66(9):4030-5
references.pmid: 9712743
references.citation: Nat Struct Mol Biol. 2005 Jul;12(7):628-9
references.pmid: 15937493
references.citation: Parasite Immunol. 1999 Feb;21(2):57-71
references.pmid: 10101716
references.citation: Fundam Clin Pharmacol. 2003 Apr;17(2):171-81
references.pmid: 12667227
references.citation: J Immunol. 2006 Feb 1;176(3):1724-32
references.pmid: 16424202
references.citation: J Infect Dis. 2001 Jun 15;183(12):1794-800
references.pmid: 11372033
references.citation: Parasitol Today. 2000 Feb;16(2):56-62
references.pmid: 10652488
references.citation: Exp Parasitol. 1987 Aug;64(1):1-11
references.pmid: 3609224
references.citation: Adv Parasitol. 2006;61:167-221
references.pmid: 16735165
references.citation: Vaccine. 2003 Jun 20;21(21-22):3058-69
references.pmid: 12798650
references.citation: J Immunol. 2004 May 15;172(10):6298-303
references.pmid: 15128819
references.citation: Trends Parasitol. 2004 Mar;20(3):117-21
references.pmid: 15036032
references.citation: J Biol Chem. 2004 Apr 2;279(14):14427-39
references.pmid: 14724285
references.citation: Curr Opin Microbiol. 2004 Aug;7(4):369-74
references.pmid: 15288623
references.citation: Parasite Immunol. 2000 Dec;22(12):639-50
references.pmid: 11123756
references.citation: Scand J Immunol. 1993 Feb;37(2):165-78
references.pmid: 8094575
references.citation: J Immunol. 1998 Dec 15;161(12):6775-83
references.pmid: 9862708
references.citation: Proc Natl Acad Sci U S A. 1988 Sep;85(18):6753-7
references.pmid: 3413122
references.citation: Vaccine. 1999 Mar 26;17(13-14):1643-9
references.pmid: 10194817
references.citation: J Mol Evol. 1994 Jan;38(1):57-99
references.pmid: 8151716
references.citation: Immunology. 1999 Apr;96(4):606-11
references.pmid: 10233748
references.citation: J Biol Chem. 2004 Jan 9;279(2):1256-61
references.pmid: 14527957
references.citation: Parasite Immunol. 1993 Nov;15(11):635-41
references.pmid: 7877840
references.citation: J Biol Chem. 1994 Nov 18;269(46):28745-51
references.pmid: 7961827
references.citation: Mol Biochem Parasitol. 1982 Nov;6(5):287-95
references.pmid: 6294515
references.citation: Infect Immun. 2007 May;75(5):2366-73
references.pmid: 17339353